Sponsor:
Sunnybrook Health Sciences Centre
Code:
NCT02917564
Conditions
Glaucoma
Choroidal Effusions
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Triamcinolone Acetonide 1 ml of 40 mg/mL suspension
Sham - Participants will not recieve the Triamcinolone Acetonide
Brief summary:
Conditions
Glaucoma
Choroidal Effusions
Study ID
NCT02917564
Start date
Oct 14, 2020
Status verified date
May, 2022
Completion date
Dec 31, 2024
Anticipated
Primary completion date
May 31, 2023
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
20 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
sham comparator: Control
active comparator: Injection
Interventions
Triamcinolone Acetonide 1 ml of 40 mg/mL suspension
Sham - Participants will not recieve the Triamcinolone Acetonide
Primary outcome measure
Central contacts
Locations
Sunnybrook Research Institute
Recruiting
Toronto, Ontario, Canada, M4N 3M5
Contacts
Principal Investigator:
Catherine M Birt, MD FRCSC
Sponsor
Sunnybrook Health Sciences Centre
Last update posted
May 4, 2022
Last verified
May, 2022
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Sunnybrook Health Sciences Centre on 2022-05-04.